FDA Recalls “Sexual Enhancement” Supplements

by Bruce Waldon | Mar 15, 2026 | Alerts, Alerts-Supplements, Dietary Supplements, FDA Safety Communication, Industry Information, Industry News, Product Recalls, US-FDA

Recall Alert: Honey-Based Dietary Supplements Contained drugs not declared on product labeling Home About Consumer Food and Beverage Supplements Regulatory Medical Devices Pharma Biologics Combination Products Veterinary AI Quality QMSR Central News Enforcement Alerts...

FDA’s AEMS: Real-Time Drug and Device Safety Monitoring

by Bruce Waldon | Mar 11, 2026 | FDA_Innovation, Industry Information, Industry News, MedWatch-System, Reg_Science, US-FDA

FDA Regulatory Innovation A move toward real-time adverse event information Home About Consumer Food and Beverage Supplements Regulatory Medical Devices Pharma Biologics Combination Products Veterinary AI Quality QMSR Central News Enforcement Alerts Innovation Contact...

FDA Approves Cerebral Folate Transport Deficiency Treatment

by Bruce Waldon | Mar 10, 2026 | FDA_Innovation, Industry Information, Industry News, New Drugs, Pharmaceuticals, Product-Innovation, Products_Drugs, US-FDA

FDA Pharmaceutical Innovation Expanded use of Wellcovorin (leucovorin calcium) tablets Home About Consumer Food and Beverage Supplements Regulatory Medical Devices Pharma Biologics Combination Products Veterinary AI Quality QMSR Central News Enforcement Alerts...

FDA Streamlines Biosimilar Development to Reduce Drug Costs

by Bruce Waldon | Mar 10, 2026 | Biologics-information, Biosimilars, FDA Approvals, FDA_Innovation, Product-Innovation, US-FDA

FDA Regulatory Innovation Streamlining the development of biosimilars Home About Consumer Food and Beverage Supplements Regulatory Medical Devices Pharma Biologics Combination Products Veterinary AI Quality QMSR Central News Enforcement Alerts Innovation Contact FDA...

FDA Inspections for Domestic and Foreign Device Manufacturers

by Bruce Waldon | Mar 9, 2026 | Analytics, Data, FOIA, Inspections, US-FDA

Home About Consumer Food and Beverage Supplements Regulatory Medical Devices Pharma Biologics Combination Products Veterinary AI Quality QMSR Central News Enforcement Alerts Innovation Contact Early Observations: Comparing FDA Inspection Outcomes Striking Difference...

A Leap in FDA Transparency – The Electronic FOIA Reading Room

by Bruce Waldon | Mar 9, 2026 | Analytics, Data, FOIA, Inspections, US-FDA

Home About Consumer Food and Beverage Supplements Regulatory Medical Devices Pharma Biologics Combination Products Veterinary AI Quality QMSR Central News Enforcement Alerts Innovation Contact Exploring FDA’s FOIA Electronic Reading Room A New Window into Inspection...